nodes	percent_of_prediction	percent_of_DWPC	metapath
Clonazepam—NAT2—urine—polycystic ovary syndrome	0.165	0.448	CbGeAlD
Clonazepam—Brotizolam—PTAFR—polycystic ovary syndrome	0.0617	0.947	CrCbGaD
Clonazepam—NAT2—endocrine gland—polycystic ovary syndrome	0.0273	0.0742	CbGeAlD
Clonazepam—CYP2E1—urine—polycystic ovary syndrome	0.0242	0.066	CbGeAlD
Clonazepam—CYP3A4—urine—polycystic ovary syndrome	0.0195	0.0531	CbGeAlD
Clonazepam—Toothache—Metformin—polycystic ovary syndrome	0.0182	0.0486	CcSEcCtD
Clonazepam—Upset stomach—Metformin—polycystic ovary syndrome	0.0169	0.0451	CcSEcCtD
Clonazepam—Heartburn—Metformin—polycystic ovary syndrome	0.0161	0.0429	CcSEcCtD
Clonazepam—Fungal infection—Metformin—polycystic ovary syndrome	0.0143	0.0383	CcSEcCtD
Clonazepam—Rhinorrhoea—Metformin—polycystic ovary syndrome	0.0137	0.0365	CcSEcCtD
Clonazepam—TSPO—embryo—polycystic ovary syndrome	0.0136	0.0369	CbGeAlD
Clonazepam—TSPO—adrenal cortex—polycystic ovary syndrome	0.0111	0.0303	CbGeAlD
Clonazepam—GABRG2—pituitary gland—polycystic ovary syndrome	0.0106	0.0289	CbGeAlD
Clonazepam—GABRA3—endocrine gland—polycystic ovary syndrome	0.0101	0.0275	CbGeAlD
Clonazepam—TSPO—endometrium—polycystic ovary syndrome	0.00993	0.027	CbGeAlD
Clonazepam—Lightheadedness—Metformin—polycystic ovary syndrome	0.0099	0.0264	CcSEcCtD
Clonazepam—Ear pain—Metformin—polycystic ovary syndrome	0.00941	0.0251	CcSEcCtD
Clonazepam—TSPO—uterus—polycystic ovary syndrome	0.00915	0.0249	CbGeAlD
Clonazepam—TSPO—pituitary gland—polycystic ovary syndrome	0.00899	0.0244	CbGeAlD
Clonazepam—TSPO—adipose tissue—polycystic ovary syndrome	0.00895	0.0243	CbGeAlD
Clonazepam—Lethargy—Metformin—polycystic ovary syndrome	0.00819	0.0219	CcSEcCtD
Clonazepam—TSPO—adrenal gland—polycystic ovary syndrome	0.00803	0.0218	CbGeAlD
Clonazepam—Migraine—Metformin—polycystic ovary syndrome	0.0079	0.0211	CcSEcCtD
Clonazepam—ALB—adrenal gland—polycystic ovary syndrome	0.00784	0.0213	CbGeAlD
Clonazepam—TSPO—female gonad—polycystic ovary syndrome	0.00748	0.0204	CbGeAlD
Clonazepam—Dehydration—Metformin—polycystic ovary syndrome	0.00747	0.02	CcSEcCtD
Clonazepam—TSPO—vagina—polycystic ovary syndrome	0.00744	0.0202	CbGeAlD
Clonazepam—Liver function test abnormal—Metformin—polycystic ovary syndrome	0.00741	0.0198	CcSEcCtD
Clonazepam—Breast disorder—Metformin—polycystic ovary syndrome	0.00725	0.0194	CcSEcCtD
Clonazepam—Cramp muscle—Metformin—polycystic ovary syndrome	0.00723	0.0193	CcSEcCtD
Clonazepam—Nasopharyngitis—Metformin—polycystic ovary syndrome	0.00718	0.0192	CcSEcCtD
Clonazepam—TSPO—endocrine gland—polycystic ovary syndrome	0.00696	0.0189	CbGeAlD
Clonazepam—Influenza—Metformin—polycystic ovary syndrome	0.00694	0.0185	CcSEcCtD
Clonazepam—Abdominal discomfort—Metformin—polycystic ovary syndrome	0.00665	0.0178	CcSEcCtD
Clonazepam—Upper respiratory tract infection—Metformin—polycystic ovary syndrome	0.00645	0.0172	CcSEcCtD
Clonazepam—Drowsiness—Metformin—polycystic ovary syndrome	0.00619	0.0165	CcSEcCtD
Clonazepam—Neuropathy peripheral—Metformin—polycystic ovary syndrome	0.00606	0.0162	CcSEcCtD
Clonazepam—Rhinitis—Metformin—polycystic ovary syndrome	0.00557	0.0149	CcSEcCtD
Clonazepam—Hypoaesthesia—Metformin—polycystic ovary syndrome	0.00553	0.0148	CcSEcCtD
Clonazepam—Oedema peripheral—Metformin—polycystic ovary syndrome	0.00547	0.0146	CcSEcCtD
Clonazepam—Connective tissue disorder—Metformin—polycystic ovary syndrome	0.00546	0.0146	CcSEcCtD
Clonazepam—Eye disorder—Metformin—polycystic ovary syndrome	0.00519	0.0139	CcSEcCtD
Clonazepam—Cardiac disorder—Metformin—polycystic ovary syndrome	0.00515	0.0138	CcSEcCtD
Clonazepam—Flushing—Metformin—polycystic ovary syndrome	0.00515	0.0138	CcSEcCtD
Clonazepam—Immune system disorder—Metformin—polycystic ovary syndrome	0.00502	0.0134	CcSEcCtD
Clonazepam—Chills—Metformin—polycystic ovary syndrome	0.00498	0.0133	CcSEcCtD
Clonazepam—Malnutrition—Metformin—polycystic ovary syndrome	0.00483	0.0129	CcSEcCtD
Clonazepam—Flatulence—Metformin—polycystic ovary syndrome	0.00476	0.0127	CcSEcCtD
Clonazepam—Muscle spasms—Metformin—polycystic ovary syndrome	0.00465	0.0124	CcSEcCtD
Clonazepam—CYP2E1—adrenal gland—polycystic ovary syndrome	0.00464	0.0126	CbGeAlD
Clonazepam—Vision blurred—Metformin—polycystic ovary syndrome	0.00456	0.0122	CcSEcCtD
Clonazepam—Tremor—Metformin—polycystic ovary syndrome	0.00453	0.0121	CcSEcCtD
Clonazepam—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.00449	0.012	CcSEcCtD
Clonazepam—Malaise—Metformin—polycystic ovary syndrome	0.00436	0.0117	CcSEcCtD
Clonazepam—Palpitations—Metformin—polycystic ovary syndrome	0.00427	0.0114	CcSEcCtD
Clonazepam—Myalgia—Metformin—polycystic ovary syndrome	0.00412	0.011	CcSEcCtD
Clonazepam—Chest pain—Metformin—polycystic ovary syndrome	0.00412	0.011	CcSEcCtD
Clonazepam—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.00409	0.0109	CcSEcCtD
Clonazepam—Discomfort—Metformin—polycystic ovary syndrome	0.00407	0.0109	CcSEcCtD
Clonazepam—CYP2E1—endocrine gland—polycystic ovary syndrome	0.00402	0.0109	CbGeAlD
Clonazepam—Oedema—Metformin—polycystic ovary syndrome	0.00395	0.0105	CcSEcCtD
Clonazepam—Infection—Metformin—polycystic ovary syndrome	0.00392	0.0105	CcSEcCtD
Clonazepam—Nervous system disorder—Metformin—polycystic ovary syndrome	0.00387	0.0103	CcSEcCtD
Clonazepam—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.00386	0.0103	CcSEcCtD
Clonazepam—Skin disorder—Metformin—polycystic ovary syndrome	0.00383	0.0102	CcSEcCtD
Clonazepam—Anorexia—Metformin—polycystic ovary syndrome	0.00376	0.0101	CcSEcCtD
Clonazepam—Hypotension—Metformin—polycystic ovary syndrome	0.00369	0.00985	CcSEcCtD
Clonazepam—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.00359	0.00961	CcSEcCtD
Clonazepam—Dyspnoea—Metformin—polycystic ovary syndrome	0.00352	0.0094	CcSEcCtD
Clonazepam—Somnolence—Metformin—polycystic ovary syndrome	0.00351	0.00937	CcSEcCtD
Clonazepam—Dyspepsia—Metformin—polycystic ovary syndrome	0.00347	0.00928	CcSEcCtD
Clonazepam—Decreased appetite—Metformin—polycystic ovary syndrome	0.00343	0.00917	CcSEcCtD
Clonazepam—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.00341	0.0091	CcSEcCtD
Clonazepam—Fatigue—Metformin—polycystic ovary syndrome	0.0034	0.00909	CcSEcCtD
Clonazepam—Constipation—Metformin—polycystic ovary syndrome	0.00337	0.00902	CcSEcCtD
Clonazepam—Feeling abnormal—Metformin—polycystic ovary syndrome	0.00325	0.00869	CcSEcCtD
Clonazepam—CYP3A4—endocrine gland—polycystic ovary syndrome	0.00324	0.0088	CbGeAlD
Clonazepam—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.00323	0.00862	CcSEcCtD
Clonazepam—Urticaria—Metformin—polycystic ovary syndrome	0.00313	0.00838	CcSEcCtD
Clonazepam—Abdominal pain—Metformin—polycystic ovary syndrome	0.00312	0.00834	CcSEcCtD
Clonazepam—Asthenia—Metformin—polycystic ovary syndrome	0.00283	0.00757	CcSEcCtD
Clonazepam—Pruritus—Metformin—polycystic ovary syndrome	0.00279	0.00746	CcSEcCtD
Clonazepam—Diarrhoea—Metformin—polycystic ovary syndrome	0.0027	0.00721	CcSEcCtD
Clonazepam—Dizziness—Metformin—polycystic ovary syndrome	0.00261	0.00697	CcSEcCtD
Clonazepam—Vomiting—Metformin—polycystic ovary syndrome	0.00251	0.0067	CcSEcCtD
Clonazepam—Rash—Metformin—polycystic ovary syndrome	0.00249	0.00665	CcSEcCtD
Clonazepam—Dermatitis—Metformin—polycystic ovary syndrome	0.00249	0.00664	CcSEcCtD
Clonazepam—Headache—Metformin—polycystic ovary syndrome	0.00247	0.00661	CcSEcCtD
Clonazepam—Nausea—Metformin—polycystic ovary syndrome	0.00234	0.00626	CcSEcCtD
Clonazepam—Clozapine—ADRA1B—polycystic ovary syndrome	0.00173	0.0264	CrCbGaD
Clonazepam—Clozapine—ADRA1A—polycystic ovary syndrome	0.00116	0.0178	CrCbGaD
Clonazepam—Clozapine—CYP1A1—polycystic ovary syndrome	0.000592	0.00908	CrCbGaD
Clonazepam—ALB—Vitamin B12 Metabolism—CRP—polycystic ovary syndrome	0.000539	0.00279	CbGpPWpGaD
Clonazepam—GABRA1—SIDS Susceptibility Pathways—AR—polycystic ovary syndrome	0.000524	0.00271	CbGpPWpGaD
Clonazepam—GABRA3—Neuronal System—CAMK2D—polycystic ovary syndrome	0.000518	0.00268	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—HSD3B1—polycystic ovary syndrome	0.000517	0.00268	CbGpPWpGaD
Clonazepam—CYP2E1—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.000509	0.00264	CbGpPWpGaD
Clonazepam—ALB—FOXA2 and FOXA3 transcription factor networks—INS—polycystic ovary syndrome	0.000507	0.00263	CbGpPWpGaD
Clonazepam—CYP2E1—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.000503	0.00261	CbGpPWpGaD
Clonazepam—CYP2E1—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.000502	0.0026	CbGpPWpGaD
Clonazepam—GABRA1—Transmission across Chemical Synapses—DLG4—polycystic ovary syndrome	0.000501	0.00259	CbGpPWpGaD
Clonazepam—GABRG2—Neuronal System—CAMK2D—polycystic ovary syndrome	0.000496	0.00257	CbGpPWpGaD
Clonazepam—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—polycystic ovary syndrome	0.000486	0.00252	CbGpPWpGaD
Clonazepam—ALB—Transmembrane transport of small molecules—ABCB6—polycystic ovary syndrome	0.000484	0.00251	CbGpPWpGaD
Clonazepam—GABRB2—Neuronal System—DLG4—polycystic ovary syndrome	0.00048	0.00249	CbGpPWpGaD
Clonazepam—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—polycystic ovary syndrome	0.000479	0.00248	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—LHB—polycystic ovary syndrome	0.000471	0.00244	CbGpPWpGaD
Clonazepam—CYP2E1—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.000463	0.0024	CbGpPWpGaD
Clonazepam—ALB—Folate Metabolism—MTHFR—polycystic ovary syndrome	0.000461	0.00239	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—HSD3B2—polycystic ovary syndrome	0.00046	0.00239	CbGpPWpGaD
Clonazepam—GABRA3—Neuronal System—DLG4—polycystic ovary syndrome	0.000458	0.00237	CbGpPWpGaD
Clonazepam—CYP3A4—Metapathway biotransformation—AKR1C2—polycystic ovary syndrome	0.000455	0.00236	CbGpPWpGaD
Clonazepam—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP17A1—polycystic ovary syndrome	0.000451	0.00234	CbGpPWpGaD
Clonazepam—CYP2E1—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000451	0.00233	CbGpPWpGaD
Clonazepam—ALB—Vitamin B12 Metabolism—INS—polycystic ovary syndrome	0.00045	0.00233	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—AKR1C1—polycystic ovary syndrome	0.000446	0.00231	CbGpPWpGaD
Clonazepam—CYP3A4—Oxidation by Cytochrome P450—CYP17A1—polycystic ovary syndrome	0.000445	0.00231	CbGpPWpGaD
Clonazepam—CYP2E1—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000444	0.0023	CbGpPWpGaD
Clonazepam—CYP3A4—Tryptophan metabolism—CYP19A1—polycystic ovary syndrome	0.000442	0.00229	CbGpPWpGaD
Clonazepam—GABRG2—Neuronal System—DLG4—polycystic ovary syndrome	0.000439	0.00227	CbGpPWpGaD
Clonazepam—ALB—Folate Metabolism—CRP—polycystic ovary syndrome	0.000438	0.00227	CbGpPWpGaD
Clonazepam—GABRA1—Neuronal System—CAMK2D—polycystic ovary syndrome	0.000434	0.00225	CbGpPWpGaD
Clonazepam—GABRA1—SIDS Susceptibility Pathways—NR3C1—polycystic ovary syndrome	0.000423	0.00219	CbGpPWpGaD
Clonazepam—CYP2E1—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.00042	0.00217	CbGpPWpGaD
Clonazepam—CYP2E1—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.000419	0.00217	CbGpPWpGaD
Clonazepam—ALB—Metabolism of lipids and lipoproteins—LPCAT2—polycystic ovary syndrome	0.000415	0.00215	CbGpPWpGaD
Clonazepam—ALB—Vitamin B12 Metabolism—SERPINE1—polycystic ovary syndrome	0.000414	0.00214	CbGpPWpGaD
Clonazepam—CYP2E1—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000413	0.00214	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—SULT2A1—polycystic ovary syndrome	0.00041	0.00213	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—GP1BB—polycystic ovary syndrome	0.000398	0.00206	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—RRM2—polycystic ovary syndrome	0.000397	0.00206	CbGpPWpGaD
Clonazepam—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—polycystic ovary syndrome	0.000394	0.00204	CbGpPWpGaD
Clonazepam—GABRA1—Neuronal System—DLG4—polycystic ovary syndrome	0.000384	0.00199	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—YAP1—polycystic ovary syndrome	0.000383	0.00199	CbGpPWpGaD
Clonazepam—CYP2E1—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000375	0.00194	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—NAMPT—polycystic ovary syndrome	0.000368	0.00191	CbGpPWpGaD
Clonazepam—ALB—Folate Metabolism—INS—polycystic ovary syndrome	0.000366	0.0019	CbGpPWpGaD
Clonazepam—ALB—Selenium Micronutrient Network—MTHFR—polycystic ovary syndrome	0.000366	0.0019	CbGpPWpGaD
Clonazepam—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	0.000366	0.0019	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—CYP11A1—polycystic ovary syndrome	0.000364	0.00188	CbGpPWpGaD
Clonazepam—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—polycystic ovary syndrome	0.000357	0.00185	CbGpPWpGaD
Clonazepam—CYP3A4—Tryptophan metabolism—CYP1A1—polycystic ovary syndrome	0.000356	0.00185	CbGpPWpGaD
Clonazepam—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	0.000353	0.00183	CbGpPWpGaD
Clonazepam—ALB—Selenium Micronutrient Network—CRP—polycystic ovary syndrome	0.000348	0.0018	CbGpPWpGaD
Clonazepam—ALB—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	0.000345	0.00179	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—AKR1C3—polycystic ovary syndrome	0.000343	0.00178	CbGpPWpGaD
Clonazepam—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—polycystic ovary syndrome	0.000343	0.00178	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—CYP17A1—polycystic ovary syndrome	0.000338	0.00175	CbGpPWpGaD
Clonazepam—ALB—Folate Metabolism—SERPINE1—polycystic ovary syndrome	0.000337	0.00174	CbGpPWpGaD
Clonazepam—CYP2E1—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000332	0.00172	CbGpPWpGaD
Clonazepam—ALB—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	0.000328	0.0017	CbGpPWpGaD
Clonazepam—ALB—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	0.000328	0.0017	CbGpPWpGaD
Clonazepam—CYP2E1—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000327	0.00169	CbGpPWpGaD
Clonazepam—ALB—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	0.000312	0.00162	CbGpPWpGaD
Clonazepam—ALB—Platelet degranulation—IGF1—polycystic ovary syndrome	0.000304	0.00157	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—TH—polycystic ovary syndrome	0.000292	0.00152	CbGpPWpGaD
Clonazepam—ALB—Selenium Micronutrient Network—INS—polycystic ovary syndrome	0.000291	0.00151	CbGpPWpGaD
Clonazepam—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.00029	0.0015	CbGpPWpGaD
Clonazepam—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—polycystic ovary syndrome	0.000289	0.0015	CbGpPWpGaD
Clonazepam—ALB—Platelet degranulation—SERPINE1—polycystic ovary syndrome	0.000289	0.0015	CbGpPWpGaD
Clonazepam—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.000288	0.00149	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—SLC2A4—polycystic ovary syndrome	0.000284	0.00147	CbGpPWpGaD
Clonazepam—GABRB2—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000284	0.00147	CbGpPWpGaD
Clonazepam—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.000284	0.00147	CbGpPWpGaD
Clonazepam—ALB—Response to elevated platelet cytosolic Ca2+—SERPINE1—polycystic ovary syndrome	0.000275	0.00142	CbGpPWpGaD
Clonazepam—ALB—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.000275	0.00142	CbGpPWpGaD
Clonazepam—GABRA3—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000271	0.00141	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—CYP19A1—polycystic ovary syndrome	0.000267	0.00139	CbGpPWpGaD
Clonazepam—ALB—Selenium Micronutrient Network—SERPINE1—polycystic ovary syndrome	0.000267	0.00139	CbGpPWpGaD
Clonazepam—CYP2E1—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000267	0.00138	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—PDE3B—polycystic ovary syndrome	0.000267	0.00138	CbGpPWpGaD
Clonazepam—GABRB2—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000264	0.00137	CbGpPWpGaD
Clonazepam—CYP2E1—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000264	0.00137	CbGpPWpGaD
Clonazepam—ALB—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.000261	0.00135	CbGpPWpGaD
Clonazepam—GABRG2—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.00026	0.00135	CbGpPWpGaD
Clonazepam—CYP3A4—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.000253	0.00131	CbGpPWpGaD
Clonazepam—GABRA3—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000252	0.00131	CbGpPWpGaD
Clonazepam—ALB—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.000249	0.00129	CbGpPWpGaD
Clonazepam—GABRG2—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000242	0.00125	CbGpPWpGaD
Clonazepam—GABRB2—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000242	0.00125	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—GNAS—polycystic ovary syndrome	0.000239	0.00124	CbGpPWpGaD
Clonazepam—CYP3A4—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.000236	0.00122	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—NMNAT3—polycystic ovary syndrome	0.000235	0.00122	CbGpPWpGaD
Clonazepam—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.000233	0.00121	CbGpPWpGaD
Clonazepam—CYP3A4—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.000233	0.00121	CbGpPWpGaD
Clonazepam—GABRA3—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000231	0.0012	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—RACGAP1—polycystic ovary syndrome	0.000229	0.00119	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—NCOR1—polycystic ovary syndrome	0.000227	0.00118	CbGpPWpGaD
Clonazepam—GABRA1—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000227	0.00118	CbGpPWpGaD
Clonazepam—GABRG2—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000221	0.00115	CbGpPWpGaD
Clonazepam—ALB—SLC-mediated transmembrane transport—SLC2A4—polycystic ovary syndrome	0.000218	0.00113	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—CYP1A1—polycystic ovary syndrome	0.000216	0.00112	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—LPCAT2—polycystic ovary syndrome	0.000215	0.00111	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—SUOX—polycystic ovary syndrome	0.000215	0.00111	CbGpPWpGaD
Clonazepam—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.000215	0.00111	CbGpPWpGaD
Clonazepam—GABRA1—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000211	0.0011	CbGpPWpGaD
Clonazepam—ALB—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.000211	0.0011	CbGpPWpGaD
Clonazepam—CYP3A4—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000209	0.00108	CbGpPWpGaD
Clonazepam—CYP3A4—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000206	0.00107	CbGpPWpGaD
Clonazepam—GABRA1—SIDS Susceptibility Pathways—VEGFA—polycystic ovary syndrome	0.000203	0.00105	CbGpPWpGaD
Clonazepam—GABRB2—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000203	0.00105	CbGpPWpGaD
Clonazepam—ALB—Metabolism—NMNAT3—polycystic ovary syndrome	0.000202	0.00105	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—MTHFR—polycystic ovary syndrome	0.000201	0.00104	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—ISYNA1—polycystic ovary syndrome	0.0002	0.00104	CbGpPWpGaD
Clonazepam—CYP2E1—Biological oxidations—POMC—polycystic ovary syndrome	0.000199	0.00103	CbGpPWpGaD
Clonazepam—ALB—Platelet degranulation—VEGFA—polycystic ovary syndrome	0.000198	0.00103	CbGpPWpGaD
Clonazepam—ALB—Vitamin B12 Metabolism—IL6—polycystic ovary syndrome	0.000197	0.00102	CbGpPWpGaD
Clonazepam—CYP3A4—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.000195	0.00101	CbGpPWpGaD
Clonazepam—CYP3A4—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.000194	0.00101	CbGpPWpGaD
Clonazepam—GABRA3—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000194	0.001	CbGpPWpGaD
Clonazepam—GABRA1—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000193	0.001	CbGpPWpGaD
Clonazepam—ALB—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.000193	0.000999	CbGpPWpGaD
Clonazepam—CYP3A4—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000192	0.000993	CbGpPWpGaD
Clonazepam—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—polycystic ovary syndrome	0.000189	0.00098	CbGpPWpGaD
Clonazepam—ALB—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.000188	0.000976	CbGpPWpGaD
Clonazepam—GABRG2—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000186	0.000962	CbGpPWpGaD
Clonazepam—ALB—Metabolism—LPCAT2—polycystic ovary syndrome	0.000185	0.000957	CbGpPWpGaD
Clonazepam—ALB—Metabolism—SUOX—polycystic ovary syndrome	0.000185	0.000957	CbGpPWpGaD
Clonazepam—ALB—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.000182	0.000945	CbGpPWpGaD
Clonazepam—CYP3A4—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000174	0.000902	CbGpPWpGaD
Clonazepam—ALB—Metabolism—ISYNA1—polycystic ovary syndrome	0.000172	0.00089	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—TEAD2—polycystic ovary syndrome	0.00017	0.000881	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—AKR1C2—polycystic ovary syndrome	0.00017	0.000881	CbGpPWpGaD
Clonazepam—ALB—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.000168	0.00087	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—PPARG—polycystic ovary syndrome	0.000163	0.000844	CbGpPWpGaD
Clonazepam—GABRA1—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000162	0.000841	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—POMC—polycystic ovary syndrome	0.000161	0.000833	CbGpPWpGaD
Clonazepam—ALB—Folate Metabolism—IL6—polycystic ovary syndrome	0.00016	0.00083	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—INS—polycystic ovary syndrome	0.00016	0.000828	CbGpPWpGaD
Clonazepam—ALB—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000157	0.000812	CbGpPWpGaD
Clonazepam—CYP3A4—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000154	0.000797	CbGpPWpGaD
Clonazepam—CYP3A4—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000152	0.000786	CbGpPWpGaD
Clonazepam—ALB—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000149	0.000771	CbGpPWpGaD
Clonazepam—ALB—Metabolism—TEAD2—polycystic ovary syndrome	0.000146	0.000757	CbGpPWpGaD
Clonazepam—ALB—Metabolism—AKR1C2—polycystic ovary syndrome	0.000146	0.000757	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—PNPLA2—polycystic ovary syndrome	0.000142	0.000738	CbGpPWpGaD
Clonazepam—GABRA1—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	0.000141	0.000728	CbGpPWpGaD
Clonazepam—ALB—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.00014	0.000728	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—PLAT—polycystic ovary syndrome	0.00014	0.000724	CbGpPWpGaD
Clonazepam—ALB—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000138	0.000716	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—SRD5A1—polycystic ovary syndrome	0.000135	0.0007	CbGpPWpGaD
Clonazepam—ALB—Platelet activation, signaling and aggregation—IGF1—polycystic ovary syndrome	0.000135	0.000698	CbGpPWpGaD
Clonazepam—ALB—Platelet activation, signaling and aggregation—AKT2—polycystic ovary syndrome	0.000135	0.000698	CbGpPWpGaD
Clonazepam—ALB—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.00013	0.000674	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—STAR—polycystic ovary syndrome	0.000129	0.000667	CbGpPWpGaD
Clonazepam—ALB—Platelet activation, signaling and aggregation—SERPINE1—polycystic ovary syndrome	0.000128	0.000663	CbGpPWpGaD
Clonazepam—ALB—Selenium Micronutrient Network—IL6—polycystic ovary syndrome	0.000127	0.000659	CbGpPWpGaD
Clonazepam—CYP3A4—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000124	0.000642	CbGpPWpGaD
Clonazepam—ALB—Metabolism—PNPLA2—polycystic ovary syndrome	0.000122	0.000634	CbGpPWpGaD
Clonazepam—CYP3A4—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000122	0.000634	CbGpPWpGaD
Clonazepam—ALB—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000121	0.000627	CbGpPWpGaD
Clonazepam—ALB—Metabolism—SRD5A1—polycystic ovary syndrome	0.000116	0.000601	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—HMMR—polycystic ovary syndrome	0.000115	0.000595	CbGpPWpGaD
Clonazepam—ALB—Metabolism—STAR—polycystic ovary syndrome	0.000111	0.000574	CbGpPWpGaD
Clonazepam—ALB—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000111	0.000573	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—HSD3B1—polycystic ovary syndrome	0.00011	0.000567	CbGpPWpGaD
Clonazepam—ALB—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000109	0.000567	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	0.000109	0.000565	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—GNAS—polycystic ovary syndrome	0.000107	0.000556	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—LHB—polycystic ovary syndrome	9.99e-05	0.000517	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	9.98e-05	0.000517	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	9.98e-05	0.000517	CbGpPWpGaD
Clonazepam—ALB—Metabolism—HMMR—polycystic ovary syndrome	9.87e-05	0.000511	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—HSD3B2—polycystic ovary syndrome	9.76e-05	0.000506	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—AKR1C1—polycystic ovary syndrome	9.45e-05	0.00049	CbGpPWpGaD
Clonazepam—ALB—Metabolism—HSD3B1—polycystic ovary syndrome	9.41e-05	0.000488	CbGpPWpGaD
Clonazepam—ALB—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	9.3e-05	0.000482	CbGpPWpGaD
Clonazepam—ALB—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	9.29e-05	0.000481	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	9.27e-05	0.00048	CbGpPWpGaD
Clonazepam—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	9.24e-05	0.000479	CbGpPWpGaD
Clonazepam—ALB—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	8.82e-05	0.000457	CbGpPWpGaD
Clonazepam—ALB—Platelet activation, signaling and aggregation—VEGFA—polycystic ovary syndrome	8.8e-05	0.000456	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—SULT2A1—polycystic ovary syndrome	8.7e-05	0.000451	CbGpPWpGaD
Clonazepam—ALB—Metabolism—LHB—polycystic ovary syndrome	8.58e-05	0.000445	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—RRM2—polycystic ovary syndrome	8.43e-05	0.000437	CbGpPWpGaD
Clonazepam—ALB—Metabolism—HSD3B2—polycystic ovary syndrome	8.39e-05	0.000435	CbGpPWpGaD
Clonazepam—ALB—Metabolism—AKR1C1—polycystic ovary syndrome	8.13e-05	0.000421	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—YAP1—polycystic ovary syndrome	8.12e-05	0.000421	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	7.89e-05	0.000409	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	7.89e-05	0.000409	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—NAMPT—polycystic ovary syndrome	7.8e-05	0.000404	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—CYP11A1—polycystic ovary syndrome	7.71e-05	0.000399	CbGpPWpGaD
Clonazepam—ALB—Metabolism—SULT2A1—polycystic ovary syndrome	7.48e-05	0.000387	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—AKR1C3—polycystic ovary syndrome	7.28e-05	0.000377	CbGpPWpGaD
Clonazepam—ALB—Metabolism—RRM2—polycystic ovary syndrome	7.24e-05	0.000375	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—CYP17A1—polycystic ovary syndrome	7.16e-05	0.000371	CbGpPWpGaD
Clonazepam—ALB—Metabolism—YAP1—polycystic ovary syndrome	6.98e-05	0.000362	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—IGF1—polycystic ovary syndrome	6.95e-05	0.00036	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—AKT2—polycystic ovary syndrome	6.94e-05	0.00036	CbGpPWpGaD
Clonazepam—ALB—Metabolism—NAMPT—polycystic ovary syndrome	6.71e-05	0.000347	CbGpPWpGaD
Clonazepam—ALB—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	6.67e-05	0.000345	CbGpPWpGaD
Clonazepam—ALB—Metabolism—CYP11A1—polycystic ovary syndrome	6.62e-05	0.000343	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	6.61e-05	0.000342	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—SERPINE1—polycystic ovary syndrome	6.6e-05	0.000342	CbGpPWpGaD
Clonazepam—ALB—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	6.58e-05	0.000341	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	6.26e-05	0.000325	CbGpPWpGaD
Clonazepam—ALB—Metabolism—AKR1C3—polycystic ovary syndrome	6.26e-05	0.000324	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—TH—polycystic ovary syndrome	6.2e-05	0.000321	CbGpPWpGaD
Clonazepam—ALB—Metabolism—CYP17A1—polycystic ovary syndrome	6.16e-05	0.000319	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—SLC2A4—polycystic ovary syndrome	6.03e-05	0.000312	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	5.98e-05	0.00031	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—CYP19A1—polycystic ovary syndrome	5.67e-05	0.000294	CbGpPWpGaD
Clonazepam—ALB—Metabolism—TH—polycystic ovary syndrome	5.33e-05	0.000276	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	5.33e-05	0.000276	CbGpPWpGaD
Clonazepam—ALB—Metabolism—SLC2A4—polycystic ovary syndrome	5.18e-05	0.000269	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	5.08e-05	0.000263	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—GNAS—polycystic ovary syndrome	5.06e-05	0.000262	CbGpPWpGaD
Clonazepam—ALB—Metabolism—CYP19A1—polycystic ovary syndrome	4.87e-05	0.000252	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—NCOR1—polycystic ovary syndrome	4.82e-05	0.00025	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	4.63e-05	0.00024	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—CYP1A1—polycystic ovary syndrome	4.57e-05	0.000237	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—VEGFA—polycystic ovary syndrome	4.54e-05	0.000235	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	4.53e-05	0.000235	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	4.39e-05	0.000227	CbGpPWpGaD
Clonazepam—ALB—Metabolism—GNAS—polycystic ovary syndrome	4.35e-05	0.000225	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—MTHFR—polycystic ovary syndrome	4.26e-05	0.000221	CbGpPWpGaD
Clonazepam—ALB—Metabolism—NCOR1—polycystic ovary syndrome	4.14e-05	0.000215	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	4.04e-05	0.000209	CbGpPWpGaD
Clonazepam—ALB—Metabolism—CYP1A1—polycystic ovary syndrome	3.93e-05	0.000204	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	3.91e-05	0.000203	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	3.77e-05	0.000195	CbGpPWpGaD
Clonazepam—ALB—Metabolism—MTHFR—polycystic ovary syndrome	3.66e-05	0.00019	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	3.62e-05	0.000188	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	3.58e-05	0.000185	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—PPARG—polycystic ovary syndrome	3.46e-05	0.000179	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—POMC—polycystic ovary syndrome	3.41e-05	0.000177	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—INS—polycystic ovary syndrome	3.39e-05	0.000176	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	3.38e-05	0.000175	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	3.32e-05	0.000172	CbGpPWpGaD
Clonazepam—ALB—Metabolism—PPARG—polycystic ovary syndrome	2.97e-05	0.000154	CbGpPWpGaD
Clonazepam—ALB—Metabolism—POMC—polycystic ovary syndrome	2.93e-05	0.000152	CbGpPWpGaD
Clonazepam—ALB—Metabolism—INS—polycystic ovary syndrome	2.91e-05	0.000151	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—TH—polycystic ovary syndrome	2.88e-05	0.000149	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	2.8e-05	0.000145	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	2.63e-05	0.000136	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	2.35e-05	0.000122	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	2.24e-05	0.000116	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	2.12e-05	0.00011	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	1.98e-05	0.000102	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	1.6e-05	8.31e-05	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	1.58e-05	8.19e-05	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—INS—polycystic ovary syndrome	1.57e-05	8.15e-05	CbGpPWpGaD
